Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events

被引:147
作者
Rundlöf, AK [1 ]
Arnér, ESJ [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden
关键词
D O I
10.1089/152308604771978336
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reactive oxygen species (ROS) are generated as toxic by-products of aerobic metabolism, but are also essential biomolecules in cell signaling. The thioredoxin (Trx) system is a major enzymatic system modulating ROS levels and is important for redox regulation of cellular function. It consists of Trx and thioredoxin reductase (TrxR), which reduces Trx using NADPH. Most, if not all, of the functions of Trx depend on the activity of TrxR. Mammalian TrxR enzymes are selenoproteins with broad substrate specificities, and alteration of cytosolic TrxR1 expression and activity is likely to be an important determinant for the control of cellular redox regulation. TrxR1 activity in cells seems to be modulated by an intricate interplay, involving a housekeeping type promoter in combination with alternative splice variants and transcriptional start sites, posttranscriptional regulation through AU-rich elements, inactivation by electrophilic agents and by itself modulating the effects of several key signaling molecules. TrxR1 activity is also intimately linked with several aspects of selenium metabolism, and hence selenoprotein function in general. Here, we summarize the current knowledge of these different levels of TrxR1 regulation in diverse cell types and in response to growth and signaling events.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 122 条
[1]   REDOX REGULATION OF FOS AND JUN DNA-BINDING ACTIVITY INVITRO [J].
ABATE, C ;
PATEL, L ;
RAUSCHER, FJ ;
CURRAN, T .
SCIENCE, 1990, 249 (4973) :1157-1161
[2]  
AGHIB DF, 1990, ONCOGENE, V5, P707
[3]   Thioredoxin reductase is the major selenoprotein expressed in human umbilical-vein endothelial cells and is regulated by protein kinase C [J].
Anema, SM ;
Walker, SW ;
Howie, AF ;
Arthur, JR ;
Nicol, F ;
Beckett, GJ .
BIOCHEMICAL JOURNAL, 1999, 342 :111-117
[4]   Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine [J].
Anestål, K ;
Arnér, ESJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :15966-15972
[5]   Physiological functions of thioredoxin and thioredoxin reductase [J].
Arnér, ESJ ;
Holmgren, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6102-6109
[6]   Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase [J].
Arner, ESJ ;
Nordberg, J ;
Holmgren, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (01) :268-274
[7]   Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex [J].
Arnér, ESJ ;
Nakamura, H ;
Sasada, T ;
Yodoi, J ;
Holmgren, A ;
Spyrou, G .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (10) :1170-1178
[8]   The oxidation of selenocysteine is involved in the inactivation of glutathione peroxidase by nitric oxide donor [J].
Asahi, M ;
Fujii, J ;
Takao, T ;
Kuzuya, T ;
Hori, M ;
Shimonishi, Y ;
Taniguchi, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19152-19157
[9]   ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins [J].
Bakheet, T ;
Frevel, M ;
Williams, BRG ;
Greer, W ;
Khabar, KSA .
NUCLEIC ACIDS RESEARCH, 2001, 29 (01) :246-254
[10]   Thioredoxin reductase as a pathophysiological factor and drug target [J].
Becker, K ;
Gromer, S ;
Schirmer, RH ;
Müller, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6118-6125